*
*
*
Mémoriser
Mot de passe oublié ?
Se connecter
Créer un compte gratuit
Se connecter avec Facebook
Fermer X
Les cookies sont necessaires au bon fonctionnement de 24hGold.com. En poursuivant votre navigation sur notre site, vous acceptez leur utilisation.
Pour en savoir plus sur les cookies...
Anglais
Francais
Abonnement
Connexion
Mot, article, auteur
Compagnie, symbole
Une mine, un projet
Pièce Or, lingot
Pièce Argent, lingot
Cours Or & Argent en
Choisissez
Chinois
Hindi
Anglais
Espagnol
Arabe
Thai
Francais
Allemand
FORUM
L'or et l'Argent monnaie
Politique, Euro, Europe
Ca fait du bien d'en parler...
L'Or et l'Argent physique
Ebay, leboncoin, les brocantes
Les actions minières
Les Analyses Techniques
L'Or et l'Argent papier
La numismatique
Economie - Bourse - Immobilier
Reflexion à partager
Orfèvrerie et Argenterie
Annonces diverses
Manipulation du prix de l'Or
Les bons plans
Les bonnes adresses
24hGold
NEWSFLOW MONDIAL
Tous
Or
Argent
Cuivre
Zinc
PGM & Diamants
Autres métaux
Pétrole et Gaz
Uranium
Sociétés Minières
OR & ARGENT PHYSIQUE
Cours Or et Argent
Comparateur Achat / Vente
Carte des professionnels
Annuaire des professionnels
Pièces d'Or par pays
Assistant Ebay pour l'Or
Liste des Pièces en Or
Pièces d'Argent par pays
Assistant Ebay pour l'Argent
Liste des Pièces en Argent
Simulateur Achat d'Or
ACTIONS MINIERES
Profils des Sociétés
Reserves, Ressources et métaux
Projets, propriétés et mines
Production
Analyse technique
Dernières découvertes
Newsflow Actions Minières
TrendPower des minières
STATISTIQUES
Statistiques par Pays
Statistiques par Métal
Métaux Précieux dans 159 monnaies
Cours des métaux
Or et Argent industriels
Indices des marchés
UNIVERSITE DE L'OR
Abécédaire des Idées Fondamentales
Essais sur l'Or et l'Argent
Abécédaire de l'Or
Analystes et Contributeurs
Commentateurs
Derniers commentaires postés
OUTILS
Convertisseur Or et Argent
Générateurs de graphiques
Nissab et Zakat en Français
Nissab et Zakat en Arabe
Rss
PRATIQUE
Publicité
Abonnez-vous
Contactez-nous
A propos de 24hGold
Accueil
>
Vertex Pharmaceuticals Incorporated
>
Communiqués de Presse
>
Health-Care Subpoenas: Should We Start to Worry
Articles
NewsFlow
La Cote de l’or et de l’argent
Market Briefing
Légende
Production
Mine développement
Découverte
Exploration
Ancien producteur
Sur Google Earth, cliquez sur les pictogrammes, pour voir les informations du projet, accéder à sa page, ou à la page de la compagnie.
Dans la même rubrique
announces expected non-cash impairment
Santos
Advance Notice - Full Year Results Conference Call
Western Areas NL
Reports Financial Results for Q2 and Provides...
Canadian Zinc
TO ACQUIRE BLACK FOX FROM PRIMERO=C2=A0
McEwen Mining
Reduced Funding Requirement
KEFI
Lupaka Gold Receives First Tranche Under Amended...
Lupaka Gold Corp.
Reports Second Quarter 2017 Results and Maintains...
Guyana Goldfields
d Share Capital and Voting Rights for Lundin Mining
Lundin Mining
Platinum Group Metals Ltd. Operational and Strategic...
Platinum Group Metals
Announces $340 Million of Non-Core Asset Sales
Devon Energy
2nd Quarter Report
Terramin
June 2017 Quarterly Activities and Cashflow Report
West African Resources
( 0 vote, 0/5 )
Imprimer l'article
Article
Commentaires
Commenter
Notation
♥
Suivre la société
Tweet
0
envoyer
0
commenter
Votre avis nous interesse, merci de laisser un commentaire ou de noter cet article.
Evaluer :
Note moyenne :0 (0 vote)
Voir les mieux notés
Communiqués de Presse de
27/01/2016
Will Vertex Pharmaceuticals’ Valuation Multiple Improve?
26/01/2016
Health Canada Approves PrORKAMBI® (lumacaftor/ivacaftor) - t...
26/01/2016
5:23 pm Vertex Pharma: Health Canada approves PrORKAMBI
26/01/2016
Orkambi: Recent Addition to the Vertex Portfolio
26/01/2016
Vertex draws upside bet before earnings
25/01/2016
Will Higher Expenses Hurt Vertex's (VRTX) 4Q Earnings?
25/01/2016
What Are Wall Street’s Estimates for Vertex Pharmaceuticals?
25/01/2016
Vertex Pharmaceuticals: What Are Analysts’ Estimates?
20/01/2016
Despite Market and Sector Risks, Why Credit Suisse Now Loves...
18/01/2016
Nivalis' N91115 Gets Orphan Drug Status for Cystic Fibrosis
15/01/2016
4 Biotech Stocks Looking Good this Earnings Season
15/01/2016
Vertex Pharmaceuticals (VRTX) Jumps: Stock Moves Up 5.8%
05/01/2016
Vertex Announces Upcoming Presentation at the J.P. Morgan He...
30/12/2015
Vertex Up 3.2% as Healthcare Sector Continued to Lure Invest...
23/12/2015
Vertex Drives IBB’s Large-Caps after Losing for Two Days
01/12/2015
Do Hedge Funds Love Intercontinental Exchange Inc (ICE)?
27/11/2015
The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, ...
23/11/2015
Vertex to Present at the Piper Jaffray Healthcare Conference...
23/11/2015
Vertex Appoints Michael J. Parini as Executive Vice Presiden...
20/11/2015
Vertex Receives EU Approval for ORKAMBI® (lumacaftor/ivacaft...
19/11/2015
Vertex Rises on Two EU Approvals for Drug, Leads XLV’s Large...
04/11/2015
Vertex to Present at the Credit Suisse Healthcare Conference...
02/11/2015
Health-Care Subpoenas: Should We Start to Worry?
02/11/2015
Here’s Why These Four Stocks Are Trending Today
02/11/2015
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Inves...
31/10/2015
Vertex Pharma receives subpoena from Department of Justice
30/10/2015
Law Offices of Howard G. Smith Commences Investigation on Be...
30/10/2015
Vertex, Mylan, CVS subpoenaed by federal agencies
30/10/2015
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On...
30/10/2015
Nivalis (NVLS): A Surprise in Store this Earnings Season?
29/10/2015
Vertex (VRTX) Posts Narrower Q3 Loss, Ups Kalydeco View
29/10/2015
Edited Transcript of VRTX earnings conference call or presen...
28/10/2015
Vertex Reports Third Quarter 2015 Financial Results
28/10/2015
Vertex reports 3Q loss
28/10/2015
4:07 pm Vertex Pharma beats by $0.14, beats on revs; raises ...
27/10/2015
Will Orkambi Help Vertex (VRTX) Post a Lower Loss in Q3?
26/10/2015
Vertex and CRISPR Therapeutics Establish Collaboration to Us...
26/10/2015
8:03 am Vertex Pharma and CRISPR Therapeutics enter strategi...
20/10/2015
Oppenheimer Incrementally More Bullish on Gilead, Remains Ca...
12/10/2015
Why Energy Stocks Outperformed the Broad Market on October 6
09/10/2015
Vertex to Announce Third Quarter 2015 Financial Results on O...
08/10/2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Invest...
08/10/2015
Vertex's Kalydeco Gets Priority Review for Expanded Use
08/10/2015
Vertex Announces Significant Progress in Its Development Eff...
07/10/2015
Supplemental New Drug Application for Use of KALYDECO® (ivac...
07/10/2015
Supplemental New Drug Application for Use of KALYDECO® (ivac...
07/10/2015
Supplemental New Drug Application for Use of KALYDECO® (ivac...
07/10/2015
BioMarin Pharmaceutical Takes a Nosedive Last Week
01/10/2015
The Zacks Analyst Blog Highlights: Regeneron, Vertex, Gilead...
29/09/2015
Regeneron and Mylan End Up in Green for the Week
28/09/2015
Why Argus Thinks Now Is the Time to Buy Vertex
25/09/2015
IBB Remained Flat Last Week
25/09/2015
Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaf...
23/09/2015
XBI’s Biotechnology Stocks Rose Week of September 11
22/09/2015
5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet
22/09/2015
Vertex Outperforms XLV on a Year-to-Date Basis
21/09/2015
Biotech stocks fall on Clinton vow to fight 'price gouging'
18/09/2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Invest...
16/09/2015
XLV and XBI Outperform Benchmark Indexes from August 25–31
14/09/2015
Amgen And Biogen Lead Short Interest Surge In Biotechs
14/09/2015
Vertex Helps Biotechnology Sector Outperform
14/09/2015
How Will Vertex Solve Its Falling Revenue Woes?
14/09/2015
Vertex Pharma's Orkambi Gives It Huge Potential, Says Barcla...
11/09/2015
Vertex and Biogen Outperformd XLV and SPY
08/09/2015
Vertex to Present at the Morgan Stanley Healthcare Conferenc...
22/08/2015
How Does Vertex Compare to Its Peers?
21/08/2015
Vertex Stock Rises after 2Q15 Results Announcement
21/08/2015
Will Orkambi Be a Game Changer for Vertex?
19/08/2015
Vertex Awards Two Boston Public High School Students the Ver...
11/08/2015
What Drove Vertex’s Revenue in 2Q15?
11/08/2015
Vertex Reports 2Q15 Revenues of $166.1 Million
11/08/2015
What Led Large-Cap Stocks to Outperform Mid and Small Caps?
10/08/2015
Key for Investors: How Are Biotech Stocks Trending?
10/08/2015
Biotech Stocks Rise Due to a Stable Market: July 31 Week
06/08/2015
The Zacks Analyst Blog Highlights: Amgen, Vertex, Regeneron,...
04/08/2015
3 Potential Huge Takeover Targets in Biotech
31/07/2015
Advanced Estimate: US 2Q Gross Domestic Product Expanded by ...
30/07/2015
Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - An...
30/07/2015
Large-Cap Healthcare Stocks Outperform Small Caps
30/07/2015
Edited Transcript of VRTX earnings conference call or presen...
29/07/2015
Vertex Reports Second Quarter 2015 Financial Results
29/07/2015
Vertex reports 2Q loss
28/07/2015
Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analy...
28/07/2015
CRBP: Warrant Exercise To Provide Sufficient Cash Through 20...
24/07/2015
What to Watch in the Week Ahead and on Monday, July 27
21/07/2015
How High? The Backlash Over Rising Prescription Drug Prices ...
14/07/2015
Vertex to Announce Second Quarter 2015 Financial Results on ...
06/07/2015
Vertex Pharma Is 'Hyped,' H.C. Wainwright Sees 35% Downside
05/07/2015
Evercore ISI Analyst Gives Highlights From Vertex's Orkambi ...
05/07/2015
1:46 pm Vertex Pharma confirms FDA approval of its ORKAMBI t...
02/07/2015
Business Highlights
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
FDA clears drug for leading form of cystic fibrosis
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacafto...
02/07/2015
Vertex Pharma's lung disorder therapy wins FDA nod
02/07/2015
Vertex Shares Leap On FDA Approval For Cystic Fibrosis Combo...
02/07/2015
FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Med...
18/06/2015
Sangeeta N. Bhatia, M.D., Ph.D., Joins Vertex Board of Direc...
12/06/2015
Edited Transcript of VRTX presentation 11-Jun-15 4:20pm GMT
08/05/2015
FDA questions benefit of cystic fibrosis drug from Vertex
23/04/2015
Why Vertex Pharmaceuticals (VRTX) Stock Might be a Great Pic...
21/04/2015
Gilead's Stock Spikes on Possibility of Vertex Deal
21/04/2015
Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC C...
21/04/2015
Bernstein: It's Time For Gilead To Pull The Trigger On This ...
17/04/2015
Biotech Investors Shouldn't Miss These Stocks This Earnings ...
15/04/2015
Will a New Vertex Drug for Cystic Fibrosis Become a Budget B...
09/04/2015
Vertex to Announce First Quarter 2015 Financial Results on A...
08/04/2015
Stock Market News for April 08, 2015 - Market News
26/03/2015
The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex,...
26/03/2015
One analyst is convinced the biotech stock plunge is 'misgui...
24/03/2015
Vertex Falls on Disappointing Kalydeco+VX-661 Combo Data - A...
24/03/2015
Vertex Treatment May Have High Risk of Failure, Analyst Sugg...
24/03/2015
Stock Market News for March 24, 2015 - Market News
23/03/2015
Deutsche Bank: Vertex Pharma's Disappointing VX-661 Trial Re...
23/03/2015
Vertex Falls Below Buy Point On Cystic-Fibrosis Drug Data
23/03/2015
Pfizer and ImmunoGen are big market movers
23/03/2015
ICYMI: Pharmaceutical Stocks Are Moving Big On Monday
Publication de commentaires terminée
Tous
Favoris
Mieux Notés
Dernier commentaire publié pour cet article
Soyez le premier à donner votre avis
Ajouter votre commentaire
CODE :
NASDAQ (VRTX)
401,08
+0.23%
US$
401,08
03/05
17:00
0,920
0,23%
Cours préc.
Ouverture
400,16
401,50
Bas
haut
397,59
405,67
Année b/h
Var. YTD
392,81
-
446,08
-2,39%
52 sem. b/h
var. 52 sem.
323,57
-
446,08
15,22%
Volume
var. 1 mois
1 041 920
-1,37%
Produit
Développe
Recherche
Profil
Indicateurs
de Marché
Communiqués
de Presse
RISQUE :
Profile actifs
Analyse
Graphique
interactif
Imprimer
Comparer
Exporter
Suivi et investissement
Ajouter une alerte
Ajouter aux Watchlists
Ajouter au portefeuille
Ajouter une note
Vous devez être connecté pour accéder au portefeuille (gratuit)
Top Newsreleases
LES PLUS LUS
Plus...
Variation annuelle
Date
Variation
Maxi
Mini
2024
-1,43%
448,40
391,02
2023
40,90%
413,00
282,41
2022
30,17%
324,75
219,10
2021
-6,14%
238,26
176,36
2020
6,96%
306,08
197,47
Graphique 5 ans
Graphique 3 mois
Graphique volume 3 mois
Nos flux RSS
24hGold Mobile
Gold Data Center
Convertisseur Or Argent
Pièces d'or sur eBay
Pièces d'argent sur eBay
Minières :
outils techniques
Minières : outils
d'analyse fondamentale
Nouvelles des Sociétés Minières
Plymouth Minerals LTD
PLH.AX
Plymouth Minerals Intersects Further High Grade Potash in Drilling at Banio Potash Project - Plannin
0,12
AU$
-8,00%
Trend Power :
Santos
(Ngas-Oil)
STO.AX
announces expected non-cash impairment
7,49
AU$
+0,13%
Trend Power :
OceanaGold
(Au)
OGC.AX
RELEASES NEW TECHNICAL REPORT FOR THE HAILE GOLD MINE
2,20
AU$
+0,00%
Trend Power :
Western Areas NL
(Au-Ni-Pl)
WSA.AX
Advance Notice - Full Year Results Conference Call
3,86
AU$
+0,00%
Trend Power :
Canadian Zinc
(Ag-Au-Cu)
CZN.TO
Reports Financial Results for Q2 and Provides Project Updates
0,12
CA$
+4,55%
Trend Power :
Stornoway Diamond
(Gems-Au-Ur)
SWY.TO
Second Quarter Results
0,02
CA$
+100,00%
Trend Power :
McEwen Mining
(Cu-Le-Zn)
MUX
TO ACQUIRE BLACK FOX FROM PRIMERO=C2=A0
11,76
US$
+1,29%
Trend Power :
Rentech
(Coal-Ngas)
RTK
Rentech Announces Results for Second Quarter 2017
0,20
US$
-12,28%
Trend Power :
KEFI
KEFI.L
Reduced Funding Requirement
0,54
GBX
-0,92%
Trend Power :
Lupaka Gold Corp.
LPK.V
Lupaka Gold Receives First Tranche Under Amended Invicta Financing Agreement
0,06
CA$
+0,00%
Trend Power :
Imperial
(Ag-Au-Cu)
III.TO
Closes Bridge Loan Financing
2,59
CA$
-0,38%
Trend Power :
Guyana Goldfields
(Cu-Zn-Pa)
GUY.TO
Reports Second Quarter 2017 Results and Maintains Production Guidance
1,84
CA$
+0,00%
Trend Power :
Lundin Mining
(Ag-Au-Cu)
LUN.TO
d Share Capital and Voting Rights for Lundin Mining
15,15
CA$
+0,80%
Trend Power :
Canarc Res.
(Au)
CCM.TO
Canarc Reports High Grade Gold in Surface Rock Samples at Fondaway Canyon, Nevada
0,24
CA$
-7,84%
Trend Power :
Havilah
(Cu-Le-Zn)
HAV.AX
Q A April 2017 Quarterly Report
0,22
AU$
+0,00%
Trend Power :
Uranium Res.
(Ur)
URRE
Commences Lithium Exploration Drilling at the Columbus Basin Project
6,80
US$
-2,86%
Trend Power :
Platinum Group Metals
(Au-Cu-Gems)
PTM.TO
Platinum Group Metals Ltd. Operational and Strategic Process ...
1,79
CA$
-2,72%
Trend Power :
Devon Energy
(Ngas-Oil)
DVN
Announces $340 Million of Non-Core Asset Sales
50,54
US$
+0,40%
Trend Power :
Precision Drilling
(Oil)
PD-UN.TO
Announces 2017Second Quarter Financial Results
8,66
CA$
-0,35%
Trend Power :
Terramin
(Ag-Au-Cu)
TZN.AX
2nd Quarter Report
0,04
AU$
+0,00%
Trend Power :
Profil de Vertex Pharmaceuticals Incorporated
|
Articles sur Vertex Pharmaceuticals Incorporated
|
Indicateurs de marché de Vertex Pharmaceuticals Incorporated
|
Présentation de l'entreprise Vertex Pharmaceuticals Incorporated
|
Management de Vertex Pharmaceuticals Incorporated
|
Graphique interactif de Vertex Pharmaceuticals Incorporated
|
Graphiques gratuits de Vertex Pharmaceuticals Incorporated
|
Vertex Pharmaceuticals Incorporated NASDAQ